No Detail Found!

Correlation of Serum Visfatin Levels with Dyslipidemia in Obese Balb/c Mice.

Author(s)
Raisa Naz Department of Physiology, Ayub Medical College Abbottabad, Pakistan
Shazia Tauqeer Department of Physiology, Ayub Medical College Abbottabad, Pakistan
Nadia Haleem Department of Biochemistry, Ayub Medical College, Abbottabad, Pakistan
Muhammad Ayub AJK Medical College Muzaffarabad, Azad Kashmir, Pakistan
Abstract
Background: Visceral adipose tissues secrete several adipocytokines that modulate on their own way the extreme obesity, diabetes, dyslipidemia, atherosclerosis and inflammation. Visfatin is newly identified adipocytokine that is released by visceral adipose tissue. Its levels markedly increase during development of obesity. The aim of this study was to determine the levels of visfatin and its association with dyslipidemia in obese albino mice. Methods: It was a quasi experimental study. Sixty (60) Balb/c strain albino mice were divided into two groups of 30 each. Group I was taken as control non obese mice while Group II animals were fed high fat/high carbohydrate diet. Blood samples were collected to measure Total Cholesterol (TC), Triglycerides (TG), High Density Lipoprotein (HDL-C), Low Density Lipoprotein (LDL-C), Very Low Density Lipoprotein (VLDL-C) and visfatin levels. Results: There was significant correlation among different classes of lipids with increasing visfatin levels in diet induced obese mice (p<0.05). TC, TG, LDL and VLDL showed significant elevation in serum levels (5.94±1.18 mmol/L, 2.92±0.15 mmol/L, 3.91±0.56 mmol/L, 1.56±0.31 mmol/L respectively) against controls (3.1±0.40 mmol/L, 1.62±0.01 mmol/L, 1.82±0.432 mmol/L, 0.60±0.13 mmol/L correspondingly). Pearson's correlation coefficient between rising serum visfatin and various classes of lipids showed strong positive correlation between visfatin and TC, TG, LDL, and VLDL, while negative correlation with serum HDL levels (p<0.05). Conclusion: Increased serum visfatin levels are strongly associated with obesity and dyslipidemia.
Publication Details
Page(s) 27-29
DOI DOI not available
Published Journal: Pakistan Journal of Physiology, Volume: 14, Issue: 1, Year: 2018

Request the full text from PASTIC

References
JewishK,QabalanY,AL-QuobailiF, 2014.Study of elevated Visfatin levels in obese diabetic and non-diabetic subjects,Int J Pharm Sci Rev Res 26 271 -4
LuLF,YangSS,WangCP,HugWC,YuTH,ChiuCA, 2009.Elevated visfatin, Pre B colony enhancing factor plasma concentration in ischemic strokes,J Stroke Cerebrovasc Dis 18 354 -9
Antuna-PuenteB,FeveB,FellahiS,BastardJ. Adipokines:, 2008.The missing link between insulin resistance and obesity,Diabetes Metab 34 2 -11
ChenCC,LiTC,LiCI,LiuCS,LinWY,WuMT, 2007.The relationship between visfatin levels and anthropometric and metabolism parameters: association with cholesterol levels in women,Metabolism 56 1216 -20
ChangYH,ChangDM,LinKC,ShinSJ,LeeYJ, 2011.Visfatin in over weight/obesity, Type 2 Diabetes Mellitus, Insulin resistance, Metabolic syndrome in cardiovascular diseases; A meta analysis and systemic review,Diabetese Metab Res Rev 27 515 -27
AtacaniI,ParlakA,AydoganU,SariO,GokDE,CayciT, 2013.The effect of valsartan treatment on visfatin levels and lipid profiles in newly diagnosed hypertensives,Turk J Med Sci 43 57 -62
AdeghateE.,Visfatin, 2008.: Structure, function and relation to diabetes mellitus and other dysfunctions,Curr Med Chem 15 1851 -62
JinH,JiangB,TangJ,LuW,WangW,ZhouL, 2008.Serum visfatin concentrations in obese adolescents and its correlation with age and high- density lipoprotein cholesterol,Diabetese Res Clin Pract 79 412 -8
KolsgaardML,WangenseenT,BrunborgC,JonerH,HolvenKB,HalvorsenB, 2009.Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome,Scand J Clin Lab Invest 69 858 -64
ArakiS,DobashiK,KuboK,KawagoiR,YammotoY., 2008.Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children,Obesity 16 384 -8
KarraschT,LeszczakS,BalaM,OberI,MartinJ,SchmidA, 2014.Short term regulation of visfatin release in vivo by oral lipid ingestion and in vitro by fatty acid stimulation,Exp Clin Endocrinol Diabetese 122 126 -34
DivkovicD,Selthofer-RelaticK,CosicA,DrenjancevicI,KristekJ,RadicR, 2014.Serum visfatin concentration in eutrophic and overweight/obese male children in early child hood,Period Biol 116 191 -6
TaskesenD,KirelB,UsT., 2012.Serum visfatin levels, adiposity and glucose metabolism in obese adolescents,J Clin Res Pediatr Endocrinol 4 76 -81
StastnyJ,Bienertova-VaskuJ,VaskuA, 2012.Visfatin and its role in obesity development,Diabetes Metab Syndr 6 120 -4
EL-ShafeyEM,El-NaggarGF,Al-BedewyMM,El SorogiH, 2012.Is there a relationship between Visfatin levels and type 2 diabetes mellitus in obese and non obese patients,J Diabetes Metab 001 -
KershawEE,FlierJS, 2004.Adipose tissue as an endocrine organ,J Clin Endocrinal Metab 89 2548 -56
DerosaG,MaffioliP,SalvadeoSA,FerrariI,GravinaA,MereuR, 2010.Sibutramine and L-carnitine compared to Sibutramine alone on insulin resistance in diabetic patients,Intern Med 49 1717 -25
ChoiKM,KimJH,ChoGJ,BaikSH,ParkHS,KimSM, 2007.Effect of exercise training on plasma visfatin and eotaxin levels,Eur J Endocrinol 157 437 -42
0

Citations

0

Downloads

90

Views